Biying Chen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Sacituzumab Tirumotecan Plus Immunotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT07686588) | Biying Chen | 2026-07-01 |
Track Biying Chen automatically
Every clearance here is in the API, with alerts when new ones post.